𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality of life questionnaires for children with cancer and childhood cancer survivors: a review of the development of available measures

✍ Scribed by Anne F. Klassen; Sonya J. Strohm; Heleen Maurice-Stam; Martha A. Grootenhuis

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
177 KB
Volume
18
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Developing a measure of health outcomes
Developing a measure of health outcomes in survivors of childhood cancer: A review of the issues
✍ Jenney, Meriel E. M. ;Kane, Robert L. ;Lurie, Nicole πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 944 KB

## Abstract The success of treatment for childhood cancer has prompted greater attention to issues of quality of life for the survivors. Work on health‐related quality of life has proceeded faster for adults than for children. This paper reviews the results of such work for adults and points to the

Quality of life of African American canc
Quality of life of African American cancer survivors : A Review of the Literature
✍ Barbara D. Powe; Jill Hamilton; Nichole Hancock; Natasha Johnson; Ramona Finnie; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 1 views

African Americans are more likely to present with advanced stages of cancer at the time of diagnosis, and their survival rates continue to lag behind those of Caucasian survivors. Although the need to address the quality of life (QOL) of cancer survivors is well documented, little is known about the

The Pediatric Cancer Quality of Life Inv
The Pediatric Cancer Quality of Life Inventory: A modular approach to measuring health-related quality of life in children with cancer
✍ Michael Seid; James W. Varni; Cheryl A. Rode; Ernest R. Katz πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 89 KB πŸ‘ 3 views

Measurement of pediatric cancer patients' health-related quality of life (HRQL) in phase III randomized, controlled clinical trials is being recognized increasingly as an essential component in evaluating the comprehensive health outcomes of modern anti-neoplastic treatment protocols. Use of a brief